SLB Limited filings document the regulatory record of a Curaçao-based operating company with common stock listed on the New York Stock Exchange under the symbol SLB. Its Form 8-K disclosures furnish quarterly earnings releases, Regulation FD operational updates, and financial information related to business performance and completed acquisition activity.
SLB proxy and governance filings cover annual meeting voting results, director elections, advisory executive compensation matters, financial statement and dividend approvals, auditor ratification, board composition, and committee assignments. Other current reports disclose director appointments or resignations, capital-market security information, and operational updates that affect reported outlook and risk disclosure.
On July 15, 2025, Schlumberger N.V. (SLB) filed a Form 8-K announcing that the U.K. Competition and Markets Authority has cleared its pending all-stock acquisition of ChampionX Corporation. This clearance is the final required regulatory approval under the April 2, 2024 Merger Agreement. With regulatory risk now removed, SLB, Sodium Holdco and Sodium Merger Sub plan to close the merger on July 16, 2025, subject only to satisfaction or waiver of the remaining contractual closing conditions.
Until the transaction consummates, SLB and ChampionX will continue to operate as separate entities. The filing contains customary forward-looking-statement disclaimers, emphasizing that unforeseen events or failure to satisfy closing conditions could still delay or terminate the deal.
For investors, the CMA decision markedly improves deal certainty, accelerates the expected timetable to completion and signals that ChampionX’s production-chemical and artificial-lift portfolio could soon be integrated into SLB’s global oilfield-services platform.